北美放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型（外束放射治疗和内束放射治疗）和应用（乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others)

No. of Pages: 80    |    Report Code: BMIRE00031021    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Radiation Oncology Market
Free Sample Buy Now
2023 年北美放射肿瘤学市场价值为 40.4723 亿美元，预计到 2031 年将达到 104.0958 亿美元；预计 2023 年至 2031 年的复合年增长率为 12.5%。

癌症患病率不断上升推动北美放射肿瘤学市场发展

癌症是一种常见的健康状况，对全球社会产生重大影响。根据世界卫生组织 (WHO) 的数据，癌症是全球首要的死亡原因，2023 年将导致 970 万人死亡和 2000 万例新发癌症病例，预计到 2050 年将达到约 3500 万例新发癌症病例。根据 WHO 2024 年报告，肺癌是全球最常见的癌症和首要死亡原因，其次是结直肠癌、肝癌、乳腺癌和胃癌，分别占总死亡人数的 18.7%、9.3%、7.8%、6.9% 和 6.8%。

癌症的患病率和发病率不断上升，对有效的治疗方案的需求也随之增加。放射疗法是癌症患者不断发展的治疗方法之一，具有有效的效果，它利用高剂量的辐射（如 X 射线、伽马射线等）杀死癌细胞。放射疗法用于癌症的早期阶段，各种类型的外束放射疗法用于治疗不同的癌症。例如，近距离放射治疗用于治疗乳腺癌、宫颈癌、眼癌、前列腺癌和头颈癌。同样，全身放射治疗也称为放射性碘，用于治疗甲状腺癌。放射治疗可用于治疗的任何阶段，并可与其他治疗相结合，如手术、化疗、免疫治疗等。因此，癌症患病率的提高和肿瘤放射治疗的发展预计将推动放射肿瘤学市场的增长。

北美放射肿瘤学市场概况

放射治疗广泛适用于美国所有癌症患者，对放射肿瘤学家的需求也在不断增加。由于医疗保健基础设施的发达，这些专业人员的数量也在不断增加。尽管如此，美国临床肿瘤学会估计全球约三分之二的癌症患者接受放射治疗作为治疗的一部分。到 2023 年，预计美国每年将有超过 100 万癌症患者接受放射治疗。政府和医疗机构正在采取多项举措来鼓励采用放射治疗。2020 年 6 月，美国放射肿瘤学会 (ASTRO) 推出了关于非转移性宫颈癌放射治疗的新临床指南。新指南侧重于精确实施放射治疗的步骤和流程。

北美放射肿瘤学市场收入和预测到 2031 年（百万美元）

北美放射肿瘤学市场细分

北美放射肿瘤学市场分为类型、应用和国家。

根据类型，北美放射肿瘤学市场分为外束放射治疗和内束放射治疗。外束放射治疗部分在 2023 年占据了更大的市场份额。

在应用方面，北美放射肿瘤学市场分为乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等。 2023 年，乳腺癌领域占据了最大的市场份额。

按国家/地区划分，北美放射肿瘤学市场分为美国、加拿大和墨西哥。2023 年，美国占据了北美放射肿瘤学市场份额的主导地位。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Perspective Therapeutics Inc、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcare 和 Curium 是北美放射肿瘤学市场的一些领先公司。

North America Radiation Oncology Strategic Insights

Strategic insights for North America Radiation Oncology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-radiation-oncology-market-strategic-framework.webp
Get more information on this report

North America Radiation Oncology Report Scope

Report Attribute Details
Market size in 2023 US$ 4,047.23 Million
Market Size by 2031 US$ 10,409.58 Million
Global CAGR (2023 - 2031) 12.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 类型
  • 外照射放射治疗
  • 内照射放射治疗
By 应用
  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 头颈癌
  • 宫颈癌
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Perspective Therapeutics Inc.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Provision Healthcare.
  • Curium.
    		•
    Get more information on this report

    North America Radiation Oncology Regional Insights

    The regional scope of North America Radiation Oncology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-radiation-oncology-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - North America Radiation Oncology Market

    1. Varian Medical Systems Inc.
    2. Elekta AB.
    3. Accuray Incorporated.
    4. IBA Worldwide (Ion Beam Applications SA).
    5. Becton Dickinson and Co.
    6. Perspective Therapeutics Inc.
    7. NTP RADIOISOTOPES.
    8. Mallinckrodt Plc.
    9. Provision Healthcare.
    10. Curium.
    Frequently Asked Questions
    How big is the North America Radiation Oncology Market?

    The North America Radiation Oncology Market is valued at US$ 4,047.23 Million in 2023, it is projected to reach US$ 10,409.58 Million by 2031.

    What is the CAGR for North America Radiation Oncology Market by (2023 - 2031)?

    As per our report North America Radiation Oncology Market, the market size is valued at US$ 4,047.23 Million in 2023, projecting it to reach US$ 10,409.58 Million by 2031. This translates to a CAGR of approximately 12.5% during the forecast period.

    What segments are covered in this report?

    The North America Radiation Oncology Market report typically cover these key segments-

  • 类型 (外照射放射治疗, 内照射放射治疗)
  • 应用 (乳腺癌, 前列腺癌, 肺癌, 头颈癌, 宫颈癌)

    • What is the historic period, base year, and forecast period taken for North America Radiation Oncology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Radiation Oncology Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in North America Radiation Oncology Market?

    The North America Radiation Oncology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Perspective Therapeutics Inc.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Provision Healthcare.
  • Curium.
    • Who should buy this report?

    The North America Radiation Oncology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Radiation Oncology Market value chain can benefit from the information contained in a comprehensive market report.

    north-america-radiation-oncology-market